Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bazhen Yimu Tablets
- Development stage
- Unknown
- Lead developer
- Qianjin Research Institute
- Administration
- Oral
01
Overview
Bazhen Yimu Tablets (八珍益母片) is a traditional Chinese medicine (TCM) formulation developed and manufactured by Qianjin Research Institute (Zhuzhou Qianjin Pharmaceutical). It is a modified version of the classic 'Bazhen' (Eight Treasures) formula, enriched with Motherwort (Yi Mu Cao). The formulation consists of nine key herbal ingredients: Leonurus japonicus (Yi Mu Cao), Codonopsis pilosula (Dang Shen), Atractylodes macrocephala (Bai Zhu), Poria cocos (Fu Ling), Glycyrrhiza uralensis (Gan Cao), Angelica sinensis (Dang Gui), Paeonia lactiflora (Bai Shao), Ligusticum striatum (Chuan Xiong), and Rehmannia glutinosa (Shu Di Huang). Bazhen Yimu Tablets are approved in China for tonifying qi and blood, regulating menstruation, and promoting blood circulation. It is primarily indicated for the treatment of irregular menstruation, menstrual disorders, and general weakness or fatigue associated with qi and blood deficiency.
- Brand names
- Qianjin
- Other names
- Bazhen Yimu PianBazhen Yimu Tablets八珍益母片
02
Targets
ESR1 (ERα)PR (Progesterone receptor)AVPR1A (Arginine vasopressin receptor 1A)ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on Bazhen Yimu Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bazhen Yimu Tablets.